Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia.

NCT00300430 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1911

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemia
Coronary Heart Disease
Mixed Dyslipidemia

Interventions

DRUG: ABT-335 and rosuvastatin calcium
DRUG: ABT-335 and atorvastatin calcium
DRUG: ABT-335 and simvastatin

Sponsor

Abbott